Notas de Prensa  

Farmacéuticas. 26 de febrero de 2018

Clintec International Expands Capabilities with the Accreditation of the Latest Generation of Medidata Rave EDC

London, United Kingdom, February 26th, 2018: Clintec International, an award winning, global Clinical Research Organisation (CRO), enhances its data management capabilities to include Medidata’s (NASDAQ: MDSO) latest generation of RAVE EDC (electronic data capture) to ensure superior operational efficiency and advanced functionality.

We, at Clintec are pleased to announce further expansion of our partnership with Medidata.  Clintec received accreditation in RAVE EDC, upgrading its suite of offerings on the Medidata Clinical Cloud® platform. As a Medidata Partner, we have implemented the industry-leading electronic data capture, management and reporting solution  (Rave EDC), the coding solution (Rave Coder), and Medidata’s clinical trial management (Edge CTMS) platforms.

Clintec’s newest advancement, Medidata’s latest Rave EDC, makes our processes more agile and scalable allowing us to offer customised and flexible solutions to our clients. Speaking about this upgraded accreditation, Dr. Buttar, Clintec International chief executive officer said, “Medidata RAVE EDC will enable us to provide our clients with the state-of-the-art capabilities that they require. It further enhances our clinical research efficiencies—accelerating study timelines, reducing development costs, while providing the highest quality. We’re excited to use this cutting-edge technology solution on Medidata’s industry-leading, unified cloud platform to manage clinical trials across all therapeutic areas and therefore elevate our client services.”

“We’re thrilled that Clintec is further expanding its use of our unified platform to include the latest generation of Rave EDC,” said Glen de Vries, Medidata president and co-founder. “This marks an important milestone in providing their clients with the full breadth of Rave solutions to improve the quality and the efficiency of global studies.”


About Clintec International

Clintec International is a global mid-market full-service Contract Research Organization (CRO) founded in Europe in 1997, which has organically grown its presence into over 50 developed and emerging countries. Clintec is positioned as one of the most geographically diverse mid-market CROs, with deep expertise in advanced functional outsourcing models for clinical research. Clintec provides innovative full-service and functional outsourcing clinical research solutions to 7 of the top 10 pharmaceutical companies in the world, as well as speciality biotechnology and medical device firms in oncology, rare diseases and other therapeutic areas. In addition, Clintec has a strong agenda for social responsibility, diversity and inclusion, by providing clinical research solutions in diverse geographic locations inclusive of Sub-Saharan African countries, aligning with not-for-profit organizations, to develop medicines for infectious diseases in countries where significant unmet needs exist.

Headquartered in the UK and now in its 21st year of significant global expansion, Clintec’s focused, flexible and forward-looking approach ensures quick and reliable results customized to the global clinical research needs of its clients.

About Medidata

Medidata is reinventing global drug and medical device development by creating the industry's leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including over 850 global pharmaceutical companies, biotech, diagnostic and device firms, leading academic medical centres, and contract research organizations.


Subir notas de prensa y convocatorias

Próximas convocatorias   

Ver todas


Busca notas de prensa por especialidad médica o enfermedad.

Ver todas


Busca notas de prensa por su fecha de edición.

  Selecciona el año

Copyright © 2018, Farmavet, S.L. Todos los derechos reservados.